Cristina Maria Terrizzano, PA-C

Cristina Terrizzano practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Cristina Terrizzano's NPI, 1811561566, was assigned on May 17, 2021. Cristina Terrizzano holds California license 62878.

Cristina Terrizzano's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Cristina Terrizzano's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Cristina Terrizzano is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Cristina Terrizzano to 4 more hospitals and 3 medical groups, each named with a free account. Cristina Terrizzano's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Cristina Terrizzano practices, 6 sites in all. Vendor and product names are available with a free account.

Physician assistant is Cristina Terrizzano's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Cristina Terrizzano is licensed in California.

CMS data shows 30 Medicare services from Cristina Terrizzano across 2 procedure codes in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $2,639 for them. Every service was in an office.

CMS counts 48 Medicare patients who saw Cristina Terrizzano in 2024. The largest group is 75 to 84, with 18 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cristina Terrizzano's median patient age at 66, with 15% women.

In 2024, Cristina Terrizzano wrote 573 Medicare Part D claims for 249 patients. 76% of them were for generic drugs. CMS names the drug for 481 of them, across 12 drugs with 11 or more claims each, at $85,831 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Cristina Terrizzano for performance year 2024, reported as part of a group. Cristina Terrizzano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cristina Terrizzano as offering telehealth.

CMS Open Payments shows 16 general payments to Cristina Terrizzano from 10 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $136.